The lymphocyte-to-monocyte ratio could predict the efficacy of PD-1 inhibitors in patients with advanced cancer

BACKGROUND: PD-1/PD-L1 inhibitors have made remarkable achievements in the field of tumor treatment. However, most patients do not benefit from PD-1/PD-L1 inhibitor therapy, and some patients experience adverse reactions. Therefore, finding ideal prognostic indicators to predict the efficacy of PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Li, Li, Linlin, Chen, Guangyu, Zhang, Yong, Gao, Quanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799307/
https://www.ncbi.nlm.nih.gov/pubmed/35117780
http://dx.doi.org/10.21037/tcr-20-1451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799307/
https://www.ncbi.nlm.nih.gov/pubmed/35117780
http://dx.doi.org/10.21037/tcr-20-1451

Ejemplares similares